Search Results - "Azuara D"

Time course of necrosis/apoptosis and neovascularization during experimental gastric conditioning.

Authors: Lamas, S. Azuara, D. de Oca, J. et al.

Source: Diseases of the Esophagus. Jun2008, Vol. 21 Issue 4, p370-376. 7p. 3 Black and White Photographs, 1 Chart, 1 Graph.

EPIDEMIOLOGY OF SPORTS INJURIES IN EUROPEAN UNION COUNTRIES.

Authors: Ríos Azuara, D. Pérez Flores, D. Ríos Alcolea, M.

Source: International Journal of Medicine & Science of Physical Activity & Sport / Revista Internacional de Medicina y Ciencias de la Actividad Física y del Deporte. 2014, Vol. 14 Issue 55, p479-494.

Phase II study of high-sensitivity genotyping of KRAS , NRAS , BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.

Authors: Santos, C Azuara, D Viéitez, J M et al.

Source: Annals of Oncology. May2019, Vol. 30 Issue 5, p796-803. 8p. 4 Charts, 1 Graph.

1897P Germline and somatic mutational landscape in a cohort of malignant pleural mesothelioma patients.

Authors: Gausachs, M. Azuara, D. López-Doriga, A. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1077-S1077. 1p.

Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease.

Authors: Mayor, R. Casadomé, L. Azuara, D. et al.

Source: British Journal of Cancer. 5/1/2009, Vol. 100 Issue 10, p1534-1539. 6p. 4 Graphs.

Role of nitric oxide in apoptosis and cell necrosis for intestinal transplantation

Authors: Azuara, D. Sola, A. Hotter, G. et al.

Source: Transplantation Proceedings. Aug2003, Vol. 35 Issue 5, p1931. 2p.

P454 A novel methylation panel for the early detection of neoplasia in high risk ulcerative colitis and Crohn's colitis patients

Authors: Ortega, T. Lobaton Azuara, D. Rodriguez-Moranta, F. et al.

Source: Journal of Crohn's & Colitis. Feb2012 Supplement 1, Vol. 6, pS190-S190. 1p.

P452 Hypermethylation status in relation to chronic inflammation of inflammatory bowel disease

Authors: Ortega, T. Lobaton Azuara, D. Rodriguez-Moranta, F. et al.

Source: Journal of Crohn's & Colitis. Feb2012 Supplement 1, Vol. 6, pS189-S189. 1p.

1712P Implementation of a molecular pre-screening program (MPP) in a network of public cancer centres for phase I clinical trial (Ph1-CT) candidates: The PREICO program.

Authors: Soto Castillo, J.J. Notario Rincon, L. Azuara, D. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS934-S934. 1p.

78P Comparative analysis of molecular alterations in colorectal cancer patients under 50 and over 50: Insights from next-generation sequencing.

Authors: Pena, M. Balsa Rodriguez, J.C. Ruffinelli Torrent, F. et al.

Source: Annals of Oncology. 2025 Supplement 1, Vol. 36, pS41-S41. 1p.

33P Unveiling the patterns: Clinical and molecular traits of brain metastases (BM) in colorectal cancer (CRC).

Authors: Pena, M. Balsa Pérez, A. Agülleiro Torrent, F. et al.

Source: Annals of Oncology. 2025 Supplement 1, Vol. 36, pS19-S19. 1p.

903P Patterns and predictors of recurrence-free survival (RFS) in salivary gland cancers (SGCs): A Spanish multicenter study.

Authors: Izquierdo Miranda, A-A. Balsa Pena, M. Tous, S. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS637-S638. 2p.

Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.

Authors: Vidal, J Bellosillo, B Vivas, C Santos et al.

Source: Annals of Oncology. Mar2019, Vol. 30 Issue 3, p439-446. 8p. 3 Charts, 2 Graphs.

906P Prognostic impact and therapeutic implications of comprehensive genomic profiling (CGP) in non-metastatic salivary gland cancers (nmSGC).

Authors: Balsa Pena, M. Canet-Hermida, J. Izquierdo Miranda, A-A. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS639-S639. 1p.

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.

Authors: Grasselli, J. Elez, E. Caratù, G. et al.

Source: Annals of Oncology. Jun2017, Vol. 28 Issue 6, p1294-1301. 8p. 2 Charts, 3 Graphs.

773P Real-world results of homologous recombination deficiency testing: Comparison between two methods on 2,655 ovarian cancer patients in Spain.

Authors: Lazaro, C. Jantus Lewintre, E. Zazo, S. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS524-S524. 1p.

Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project.

Authors: Sàbat P Ajenjo-Bauza M Hierro C et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 May 15; Vol. 239, pp. 116728. Date of Electronic Publication: 2026 Apr 04.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

ClinBioNGS: A Clinical Bioinformatics Pipeline for Integrated Analysis of Somatic Next-Generation Sequencing Cancer Panels.

Authors: Marín R Alay A Ajenjo-Bauza M et al.

Source: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2026 Jan; Vol. 10, pp. e2500221. Date of Electronic Publication: 2026 Jan 08.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101708809 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4276 (Electronic) Linking ISSN: 24734276 NLM ISO Abbreviation: JCO Clin Cancer Inform Subsets: MEDLINE

Comprehensive analysis and ACMG-based classification of CHEK2 variants in hereditary cancer patients.

Authors: Vargas-Parra G Del Valle J Rofes P et al.

Source: Human mutation [Hum Mutat] 2020 Dec; Vol. 41 (12), pp. 2128-2142. Date of Electronic Publication: 2020 Oct 14.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9215429 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1004 (Electronic) Linking ISSN: 10597794 NLM ISO Abbreviation: Hum Mutat Subsets: MEDLINE

Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre.

Authors: Mosteiro M Azuara D Villatoro S et al.

Source: ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102197. Date of Electronic Publication: 2023 Dec 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE